Related Experiment Video

Updated: May 15, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders

Yao Yuan1, Siddha Kasar, Chingiz Underbayev

  • 1New Jersey Medical School, Newark, NJ 08731, USA.

Leukemia Research and Treatment
|December 22, 2012
PubMed

Insights

MicroRNA abnormalities are common in blood disorders like leukemia and autoimmune diseases. These microRNA alterations present potential therapeutic targets for treating conditions such as acute myeloid leukemia and systemic lupus erythematosus.

Area of Science:

  • Hematology
  • Molecular Biology
  • Immunology

Background:

  • Blood disorders, including leukemias and plasma cell dyscrasias, are frequently associated with microRNA abnormalities.
  • Immune disorders characterized by altered antibody levels, such as systemic lupus erythematosus (SLE) and immunoglobulin A nephropathy (IgAN), also exhibit related microRNA dysregulation.

Purpose of the Study:

  • To identify and discuss specific microRNA alterations in various blood and immune disorders.
  • To explore the potential of these microRNA abnormalities as therapeutic targets.

Main Methods:

  • Review and discussion of scientific literature pertaining to microRNAs in leukemia and immune disorders.
  • Identification of specific leukemias (e.g., acute myeloid leukemia, chronic lymphocytic leukemia) and immune disorders (e.g., SLE, IgAN) with documented microRNA changes.

Main Results:

  • Specific microRNAs and their corresponding targets have been identified as altered in acute myeloid leukemia and chronic lymphocytic leukemia.
  • MicroRNA abnormalities are also linked to autoimmune disorders like SLE and IgAN, involving anti-self-autoantibodies and immunoglobulin A.

Conclusions:

  • Altered microRNAs are a common feature across diverse blood and immune system disorders.
  • MicroRNA dysregulation represents a promising avenue for developing novel therapeutic strategies for these conditions.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...